Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 401 a 420 di 503
Titolo Data di pubblicazione Autore(i) File
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival 2014 Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U
Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM) 2011 G MORGAN; B DURIE; J SAN MIGUEL; R ORLOWSKI; S LONIAL; A PALUMBO; R NIESVIZKY; R BAZ; S GIRALT; W BENSINGER; N BRANDENBURG; Z YU; M BOCCADORO; P RICHARDSON; K ANDERSON; B BARLOGIE
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia. 2003 ROSTI G; TRABACCHI E; BASSI S; BONIFAZI F; DE VIVO A; MARTINELLI G; ALBERTI; D; FINCATO G; G. SAGLIO; BACCARANI M; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC; MYELOID LEUKEMIA.
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 2001 GUGLIELMI C ;MARTELLI M ;FEDERICO M ;ZINZANI PL ;VITOLO U ;BELLESI G ;SANTINI G ;TARELLA C ;ZALLIO F ;PREGNO P ;DI RENZO N ;RESEGOTTI L
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 2016 S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio
Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) 2002 Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio
ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE 2013 Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA 2013 Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 2015 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive? 2016 Ferrero, Simone
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 2004 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 2010 Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A
SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION 2006 L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily 2014 T. P. Hughes;A. Hochhaus;H. M. Kantarjian;F. Cervantes;F. Guilhot;D. Niederwieser;P. D. le Coutre;G. Rosti;G. Ossenkoppele;C. Lobo;H. Shibayama;X. Fan;H. D. Menssen;C. Kemp;R. A. Larson;G. Saglio
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials. 2013 Palumbo A1; Waage A; Hulin C; Beksac M; Zweegman S; Gay F; Gimsing P; Leleu X; Wijermans P; Sucak G; Pezzatti S; Juliusson G; Pégourié B; Schaafsma M; Galli M; Turesson I; Kolb B; van der Holt B; Baldi I; Rolke J; Ciccone G; Wetterwald M; Lokhorst H; Boccadoro M; Rodon P; Sonneveld P.
Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin. 1990 ALFARANO A.; GOTTARDI E.; SERRA A.; PIGA A.; MANDRINO M.; MAZZA U.; CAMASCHELLA C.
Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. 2004 M. De Gobbi;S. D'Antico;F. Castagno;D. Testa;R. Merlini;A. Bondi;C. Camaschella
se of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation. 1990 Tarella C; Gavarotti P; Caracciolo D; Locatelli F; Falda M; Paolino F; Lovisone E; Sormano E; Tassi V; Urgesi A; et al.
SECOND GENERATION TYROSINE KINASE INHIBITORS CAN INDUCE COMPLETE MOLECULAR RESPONSE IN PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANT 2010 Ulisciani S; Fava C; Falda M; Locatelli F;Busca A; D'Ardia S; Gottardi E; Daraio F; Giugliano E; Giaretto L; Saglio G; Rege Cambrin G
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi 2017 Zaja, Francesco; Ferrero, Simone; Stelitano, Caterina; Ferrari, Angela; Salvi, Flavia; Arcari, Annalisa; Musuraca, Gerardo; Botto, Barbara; Spina, Michele; Cellini, Claudia; Patti, Caterina; Liberati, Anna M.; Minotto, Claudia; Pileri, Stefano A.; Ceccarelli, Manuela; Volpetti, Stefano; Ferranti, Antonella; Drandi, Daniela; Montechiarello, Elisa; Ladetto, Marco; Carmichael, James; Fanin, Renato
Mostrati risultati da 401 a 420 di 503
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile